Aptahem is active within biotechnology. The company conducts research and development of aptamer-based pharmaceuticals for the treatment of acute conditions caused by sepsis, blockage of blood vessels, stroke, and heart failure. Through early treatment, the pharmaceutical is intended to prevent damage to organs and tissue. A large part of the research is carried out in collaboration with partners within the industry. The company was founded in 2014 and is based in Malmö.

Kurser for Aptahem AB

Lige nu

+/-
-0,03
%
-1,36%
Seneste
2,17
Højeste
2,21
Laveste
2,02
Volumen
90 653
Omsætning (SEK)
190 654
Værdi (MSEK)
103,9

Bestyrelse og direktion

Adm. direktør

  • Mikael Lindstam

Bestyrelsesformand

  • Kjell Stenberg

Bestyrelse

  • Cristina Glad
  • Johan Lindh
  • Mikael Lindstam
  • Theresa Comiskey Olsen

Film

Største ejere

Navn Kapital % Stemmer % Dato
Ivar Nordqvist 27,53 27,53 2019-02-19
Nordnet Pensionsförsäkring 12,21 12,21 2019-12-31
Avanza Pension 5,34 5,34 2019-12-31
AB Svedala Finans 2,40 2,40 2019-12-31
Adel Hanna 1,29 1,29 2019-12-31
Johan Magnus Lindh 1,13 1,13 2019-12-31
Gunvald Berger 1,13 1,13 2019-12-31
Tina Kerstin Veronica Persson 1,10 1,10 2019-12-31
Susanna Sundin 0,86 0,86 2019-12-31
Tommy Schantli 0,67 0,67 2019-12-31
** Holdings af Modular Finance AB. Sammenstilt og bearbejdet fra blandt andet Euroclear, Morningstar og Finansinspektionen.

Insiderhandel

Nøgletal

*Kompileret data fra Millistream

Kommende rapporter

  • 2020-05-14 Delårsrapport 2020-Q1

  • 2020-06-03 Årsstämma 2019

  • 2020-08-26 Delårsrapport 2020-Q2

  • 2020-11-18 Delårsrapport 2020-Q3